Skip NavigationSkip to Content

Decreased antibiotic susceptibility driven by global remodeling of the Klebsiella pneumoniae proteome

  1. Author:
    Keasey, Sarah L
    Suh, Moo-Jin [ORCID]
    Das, Sudipto
    Blancett, Candace D
    Zeng, Xiankun
    Andresson, Thorkell
    Sun, Mei G
    Ulrich, Robert G [ORCID]
  2. Author Address

    USAMRIID, United States of America., Frederick National Laboratory for Cancer Research., Frederick National Laboratory for Cancer Research, United States., USAMRMC, United States of America., United States Army Medical Research Institute of Infectious Diseases, United States of America rulrich@bhsai.org.,
    1. Year: 2019
    2. Date: Apr
    3. Epub Date: 2019 01 07
  1. Journal: Molecular & cellular proteomics : MCP
    1. 18
    2. 4
    3. Pages: 657-668
  2. Type of Article: Article
  3. Article Number: RA118.000739
  4. ISSN: 1535-9476
  1. Abstract:

    Bacteria can circumvent the effect of antibiotics by transitioning to a poorly understood physiological state that does not involve conventional genetic elements of resistance. Here we examine antibiotic susceptibility with a Class A ß-lactamase+ invasive strain of Klebsiella pneumoniae that was isolated from a lethal outbreak within laboratory colonies of Chlorocebus aethiops sabaeus monkeys. Bacterial responses to the ribosomal synthesis inhibitors streptomycin and doxycycline resulted in distinct proteomic adjustments that facilitated decreased susceptibility to each antibiotic. Drug-specific changes to proteomes included proteins for receptor-mediated membrane transport and sugar utilization, central metabolism, and capsule production, while mechanisms common to both antibiotics included elevated scavenging of reactive oxygen species and turnover of misfolded proteins. Resistance to combined antibiotics presented integrated adjustments to protein levels as well as unique drug-specific proteomic features. Our results demonstrate that dampening of Klebsiella pneumoniae susceptibility involves global remodeling of the bacterial proteome to counter the effects of antibiotics and stabilize growth. Published under license by The American Society for Biochemistry and Molecular Biology, Inc.

    See More

External Sources

  1. DOI: 10.1074/mcp.RA118.000739
  2. PMID: 30617156
  3. WOS: 000466934700004
  4. PII : RA118.000739

Library Notes

  1. Fiscal Year: FY2018-2019
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel